Daxxify
Generic name: DaxibotulinumtoxinA-lanm
Dosage form: lyophilized powder for injection
Drug class:
Skeletal muscle relaxants
Usage of Daxxify
Daxxify (DaxibotulinumtoxinA-lanm) injection is used for the temporary improvement of frown lines (glabEllar lines) and for the treatment of cervical dystonia in adults. Daxxify is a long-lasting Botulinum toxin injection that relaxes the affected muscles, which can reduce frown lines or the spasming and stiffness from cervical dystonia. Daxxify lasts longer than other first-generation botulinum toxins as it is formulated with a unique stabilizer (cell-penetrating peptide).
Daxxify is an acetylcholine release inhibitor and neuromuscular blocking agent. Daxxify works by blocking the transmission of specific chemical signals from nerves, mainly signals those cause muscles to contract. It works on frown lines by temporarily relaxing the facial muscles that cause the lines, which reduces their appearance. Daxxify works to treat cervical dystonia by relaxing muscles, which relieves abnormal involuntary movements and postures.
Daxxify became an FDA-approved medicine on September 8, 2022, for moderate to severe frown lines (glabellar lines) in adults. Then on August 11, 2023, it became FDA-approved to treat cervical dystonia in adults. Approval for cervical dystonia was based on positive results from the Phase 3 clinical program (ASPEN 1, ASPEN OLS), which showed a median length of time that it lasted for cervical dystonia was 24.0 and 20.3 weeks for each trial.
Daxxify side effects
Common Daxxify side effects
Side effects when used for frown lines:
Side effects when used for Cervical Dystonia:
Serious Daxxify side effects
Also see Warnings below.
Heart problems. Irregular heartbeat and heart attack that have resulted in death, have happened in some people who received botulinum toxin products.
Eye problems. Dry eye, reduced blinking, and corneal problems have happened in some people who receive this medicine to treat glabellar lines. Tell your healthcare provider if you develop eye pain or irritation, sensitivity to light, or changes in your vision.
Allergic reactions. Symptoms of an allergic reaction may include itching, rash, redness, swelling, wheezing, trouble breathing, dizziness, or feeling faint. Tell your healthcare provider or get medical help right away if you have wheezing or trouble breathing or if you feel dizzy or faint.
These are not all the possible side effects. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Revance Therapeutics, Inc. at 1-877-373-8669.
Before taking Daxxify
Before receiving this medicine, tell your healthcare provider about all of your medical conditions, including if you:
Pregnancy
Tell your healthcare provider if you are pregnant or plan to become pregnant. It is not known if Daxxify can harm your unborn baby.
Breastfeeding
Tell your healthcare provider if you are breastfeeding or plan to breastfeed. It is not known if Daxxify passes into your breast milk. Talk to your healthcare provider about the best way to feed your baby during treatment.
Relate drugs
- AbobotulinumtoxinA
- Amrix
- Antiflex
- Comfort Pac w/Tizanidine
- Cyclobenzaprine
- Myobloc
- Baclofen
- Baclofen (Intrathecal)
- Baclofen (Oral)
- Botox
- Botox Cosmetic
- Carisoprodol
- Chlorzoxazone
- Dantrium
- Dantrium Intravenous
- Dantrolene
- Dantrolene (Intravenous)
- Dantrolene (Oral)
- DaxibotulinumtoxinA
- Daxibotulinumtoxina-lanm
- Daxxify
- Dysport
- Fexmid
- FIRST Baclofen
- Fleqsuvy
- Flexeril
- FusePaq Tabradol
- Gablofen
- IncobotulinumtoxinA
- Jeuveau
- Lioresal
- Lorzone
- Lyvispah
- Metaxalone
- Methocarbamol
- Methocarbamol (Injection)
- Methocarbamol (Oral)
- Mio-Rel
- Norflex
- Norflex (Orphenadrine Injection)
- Norflex (Orphenadrine Oral)
- OnabotulinumtoxinA
- Orfro
- Orphenadrine
- Orphenadrine (Injection)
- Orphenadrine (Oral)
- Orphenate
- Ozobax
- Paraflex
- Parafon Forte DSC
- PrabotulinumtoxinA
- Prabotulinumtoxina-xvfs
- Remular-S
- Revonto
- RimabotulinumtoxinB
- Robaxin
- Robaxin (Methocarbamol Injection)
- Robaxin (Methocarbamol Oral)
- Robaxin-750
- Ryanodex
- Skelaxin
- Soma
- Tizanidine
- Vanadom
- Xeomin
- Zanaflex
- Zanaflex Capsule
How to use Daxxify
Usual Adult Dose for Glabellar Lines
Dose: 0.1 mL (8 Units) by intramuscular injection into each of five sites, for a total dose of 40 Units.
Usual Adult Dose for Cervical Dystonia
Dose: 125 Units to 250 Units given intramuscularly as a divided dose among affected muscles.
Daxxify is available as 50 Units or 100 Units of sterile lyophilized powder in a single-dose vial.
Warnings
This medicines may cause serious side effects that can be life-threatening. Call your healthcare provider or get medical help right away if you have any of these problems after treatment:
Problems swallowing, speaking, or breathing. These problems can happen hours, days, or weeks after an injection of Daxxify if the muscles that you use to breathe and swallow become weak after the injection. Death can happen as a complication if you have severe problems with swallowing or breathing after treatment.
Spread of toxin effects. In some cases, the effect of botulinum toxin may affect areas of the body away from the injection site and cause symptoms of a serious condition called botulism. The symptoms of botulism include:
These symptoms can happen hours, days, or weeks after you receive an injection.
These problems could make it unsafe for you to drive a car or do other dangerous activities.
What other drugs will affect Daxxify
Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
Using Daxxify with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your healthcare provider that you have received Daxxify in the past.
Especially tell your healthcare provider if you:
Know the medicines you take. Keep a list of your medicines with you to show your healthcare provider and pharmacist each time you get a new medicine.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions